Search by Practice
Latest Updates / Investments
March 20, 2019
Barnea Represented Danel Ltd. in the Acquisition of Levinger Group
Our firm represented Danel Ltd. in a deal to acquire 51% of Levinger Group. This marks a strategic move by Danel to expand into the private health field.
November 20, 2018
Barnea represented Senetas Corporation Ltd.
Our firm represented Senetas Corporation in a USD 8 million investment in the Israeli cyber company Votiro Cybersec Global Limited
October 26, 2018
Year in Review - Technology
In March 2018 the Israel Innovation Authority launched a $264 Million National Digital Health Program, with the aim of promoting Israel as a leader in digital health, and improving the quality and quantity of digital health data to support the research and development of preventive and personalize medicine. The program includes a new National Genomic-Clinical Initiative, aimed at sequencing and analyzing the genomes of 100,000 Israeli volunteers, for the purpose of aiding drug discovery.
July 30, 2018
Barnea Represented JJDC as the Lead Investor in OrthoSpin Ltd.
Our firm represented the US pharmaceutical and medical devices company Johnson Johnson Development Corporation (JJDC) in a USD 3 million lead investment round in OrthoSpin Ltd. OrthoSpin is an Israeli-based startup that provides smart robotic external fixation systems.
June 11, 2018
Barnea Represented Investor in Israeli Cybersecurity Company Claroty
Barnea advised an investor in relation to a $60 million investment in cybersecurity company Claroty. The company specializes in cybersecurity for industrial control networks.
May 9, 2018
Barnea Represented ADM Capital in Investment in Israeli Startup Rootility
Barnea represented ADM Capital, a UK-based investment fund, in an investment round in the Israeli plant-breeding startup Rootility.
April 10, 2018
IFLR 2018 M&A Israel Report
A report on the MA market in Israel was written by Adv. Ariella Dreyfuss and published on the international IFLR 1000 ranking guide's website. The report analyzes the trends and developments in the MA market in Israel.
March 27, 2018
Barnea Represented Cellebrite in the Sale of the Mobilogy Division to a US Fund
Our firm represented Cellebrite in the sale of the Mobilogy Division to the American ESW Capital Fund. The Mobilogy division, which operates as a separate brand, offers technological solutions for operators, retailers and aftermarket that enhance the customer experience in-store beyond.
February 1, 2018
Barnea Advised on the $703 Million Acquisition of Theramex by CVC
Barnea Advised on the $703 Million Acquisition of Theramex by CVC Capital Partners. Theramex is Teva Pharmaceutical Industries' global women’s health portfolio.
December 11, 2017
Barnea & Co. Represented EXO Technologies in Acquisition by Lear
Barnea represented Israeli startup EXO Technologies, a developer of GPS technology for autonomous and connected vehicle applications, in its acquisition by the American corporation Lear.